News
Stay up to date with GenLumina’s activities by subscribing to our newsletter.
Exciting News: We’re Among the 40 Most Promising Startup
Our future market is Europa, Japan and US. If we make to the top 10 startups, we get to explore the market in US in this early stage!
Genlumina Founded in Leiden: Pioneering Cancer Treatment with Light-Activated Drugs
Learn how Genlumina, founded in Leiden on August 13, 2024, is using light-activated treatments to bring new possibilities to cancer care.